Medtech Talk

Episode: 168 - Alleviant Medical CEO Adam Berman on the No-Implant Device Treating Diastolic Heart Failure

June 21, 2022 Healthegy Season 2 Episode 168
Episode: 168 - Alleviant Medical CEO Adam Berman on the No-Implant Device Treating Diastolic Heart Failure
Medtech Talk
More Info
Medtech Talk
Episode: 168 - Alleviant Medical CEO Adam Berman on the No-Implant Device Treating Diastolic Heart Failure
Jun 21, 2022 Season 2 Episode 168
Healthegy

Host Geoff Pardo talks with Adam Berman, CEO of Alleviant Medical, about the groundbreaking device treating heart failure without hardware or permanent implants. The Alleviant device mitigates shortness of breath in patients with diastolic heart failure by leaving behind a shunt cut from interatrial septum tissue. The shunt moves blood from the left atrium to the right, diminishing pressure on the lungs. Berman speaks about his start in biomedical engineering, gaining invaluable experience in the operating room, developing sales tactics and industry knowledge as a medical device field representative, and switching gears to create novel devices for cardiac care.  

Links from this episode:  
Alleviant Medical 

Show Notes

Host Geoff Pardo talks with Adam Berman, CEO of Alleviant Medical, about the groundbreaking device treating heart failure without hardware or permanent implants. The Alleviant device mitigates shortness of breath in patients with diastolic heart failure by leaving behind a shunt cut from interatrial septum tissue. The shunt moves blood from the left atrium to the right, diminishing pressure on the lungs. Berman speaks about his start in biomedical engineering, gaining invaluable experience in the operating room, developing sales tactics and industry knowledge as a medical device field representative, and switching gears to create novel devices for cardiac care.  

Links from this episode:  
Alleviant Medical